| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914809 | Molecular Oncology | 2015 | 12 Pages |
Abstract
ATM kinase inhibition overcomes radioresistance of GBM CSCs and, in combination with conventional therapy, has potential to improve outcomes for patients with GBM.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ross Carruthers, Shafiq U. Ahmed, Karen Strathdee, Natividad Gomez-Roman, Evelyn Amoah-Buahin, Colin Watts, Anthony J. Chalmers,